Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer

NCT02423148 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Co-investigator left facility. Decided not to enroll patients therefore.

Conditions

Lung Cancer

Interventions

DRUG: Indocyanine green (ICG)
DEVICE: FluoSCOPE

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]